DTx and Pharma are a natural fit

Chronic lifestyle-related diseases are a global epidemic, causing 68% of all global deaths and 80% of all health costs. Sidekick’s digital therapeutics (DTx) platform tackles this ballooning problem by encouraging lasting lifestyle and behavioral change. Only 10-20% of positive health outcomes are due to medical care, while up to 50% is linked to behavior. A bricks-and-mortar approach is unsustainable, even obsolete, with an ever growing need to prevent, reduce and manage chronic illnesses. Sidekick’s clinically validated platform is rooted in behavioral economics and scalable across multiple therapeutic areas (TAs), proven to deliver results in alliance with global pharmaceutical majors.